Cargando…
Inhalable microparticles as drug delivery systems to the lungs in a dry powder formulations
Inhalation-administrated drugs remain an interesting possibility of addressing pulmonary diseases. Direct drug delivery to the lungs allows one to obtain high concentration in the site of action with limited systemic distribution, leading to a more effective therapy with reduced required doses and s...
Autores principales: | Knap, Karolina, Kwiecień, Konrad, Reczyńska-Kolman, Katarzyna, Pamuła, Elżbieta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845529/ https://www.ncbi.nlm.nih.gov/pubmed/36683752 http://dx.doi.org/10.1093/rb/rbac099 |
Ejemplares similares
-
Insight in Superiority of the Hydrophobized Gentamycin in Terms of Antibiotics Delivery to Bone Tissue
por: Kwiecień, Konrad, et al.
Publicado: (2022) -
Composites Based on Gellan Gum, Alginate and Nisin-Enriched Lipid Nanoparticles for the Treatment of Infected Wounds
por: Reczyńska-Kolman, Katarzyna, et al.
Publicado: (2021) -
Inhalable Nanoparticles/Microparticles of an AMPK and Nrf2 Activator for Targeted Pulmonary Drug Delivery as Dry Powder Inhalers
por: Acosta, Maria F., et al.
Publicado: (2020) -
Evaluation of the In Vitro Stability of Stimuli-Sensitive
Fatty Acid-Based Microparticles for the Treatment of Lung Cancer
por: Dałek, Paulina, et al.
Publicado: (2020) -
Excipient Interactions in Glucagon Dry Powder Inhaler Formulation for Pulmonary Delivery
por: Rashid, Md Abdur, et al.
Publicado: (2019)